Metformin and Aging

Metformin shows promise in delaying age-related diseases, with studies indicating significant reductions in mortality and hospitalization during COVID for those taking the drug. It targets key hallmarks of aging, particularly immune decline, and has demonstrated efficacy in preventing long COVID. The potential of metformin as a tool for extending healthspan is compelling, prompting a call for further exploration despite the need for caution in its use beyond FDA-approved applications.